Private Advisor Group, LLC Athenex, Inc. Transaction History

Private Advisor Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Apr 01, 2021	SELL	$11.06 - $14.01 $136,955 - $173,485	-12,383 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$10.26 - $14.55 $5,130 - $7,275	-500 Reduced 3.88%	12,383 $150,000
Q2 2020 Aug 17, 2020	SELL	$7.11 - $13.76 $2,488 - $4,816	-350 Reduced 2.64%	12,883 $177,000
Q1 2020 May 12, 2020	SELL	$5.71 - $15.85 $6,161 - $17,102	-1,079 Reduced 7.54%	13,233 $102,000
Q4 2019 Feb 10, 2020	SELL	$9.6 - $17.75 $21,686 - $40,097	-2,259 Reduced 13.63%	14,312 $219,000
Q3 2019 Nov 13, 2019	SELL	$12.16 - $21.0 $6,323 - $10,920	-520 Reduced 3.04%	16,571 $202,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $84 - $178	-9 Reduced 0.05%	17,091 $338,000
Q1 2019 May 13, 2019	BUY	$11.11 - $13.49 $99 - $121	9 Added 0.05%	17,100 $210,000
Q4 2018 Feb 11, 2019	BUY	$10.24 - $15.49 $10,147 - $15,350	991 Added 6.16%	17,091 $217,000
Q3 2018 Nov 01, 2018	BUY	$15.53 - $19.97 $250,033 - $321,517	16,100 New	16,100 $250,000
Q2 2018 Aug 09, 2018	SELL	$15.88 - $19.5 $242,424 - $297,687	-15,266 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$13.53 - $17.47 $66,499 - $85,865	4,915 Added 47.48%	15,266 $260,000
Q4 2017 Feb 07, 2018	BUY	$14.41 - $19.15 $149,157 - $198,221	10,351	10,351 $161,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.